The FDA is requesting feedback on three new draft guidances related to clinical trials, including how they should be applied to increasingly diverse trial types and data sources.
Califf faced strong opposition but was confirmed in a very close vote.
President Biden intends to nominate former FDA Commissioner Robert Califf, M.D. as agency head, and the same opposition voiced during his previous nomination remains.
Although the U.S. Senate vote to appoint the new agency commissioner was overwhelming, it was not without critics.
Industry doesn’t anticipate roadblocks from the Senate, expects confirmation.